YasushiKisanukiMD

PubMed

• 38 citations
  Histamine‐1 receptor is not required as a downstream effector of orexin‐2 receptor in maintenance of basal sleep/wake states
  Mari Hondo, Kanji Nagai, Kousaku Ohno, Yasushi Kisanuki, Jon T. Willie
  Acta Physiologica. 2010-03-01
• 77 citations
  Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis.
  P. Barton Duell, Gerald Salen, Florian Eichler, Andrea E. DeBarber, Sonja L. Connor
  Journal of Clinical Lipidology. 2018-09-01
• 77 citations
  Low Blood Pressure in Endothelial Cell–Specific Endothelin 1 Knockout Mice
  Yaz Y. Kisanuki, Noriaki Emoto, Takashi Ohuchi, Bambang Widyantoro, Keiko Yagi
  Hypertension. 2010-07-01

Journal Articles

• Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendious xanthomatosis  
  Duell PB, Salen G, Eichler FS, DeBarber AE, Connor SL, Casaday L, Jayadev S, Kisanuki Y, Lekprasert P, Malloy MJ, Ramdhani RA, Ziajka PE, Quinn JF, Su KG, Geller AS, D..., J Clin Lipidol., 1/22/2018
• Teaching NeuroImages: Cerebrotendinous Xanthomatosis; A Rare Adult-Onset Lipid Storage Disease  
  Makary MS, Kisanuki YY*, Amin NN, Slone HW, Neurology, 1/1/2018
•  
  Shinagawa S, Okazaki T, Ikeda M, Yudoh K, Kisanuki YY*, Yanagisawa M, Kawahata K, Ozaki S, Sci. Rep., 1/3/2017
• Primary Lateral Sclerosis and Early Upper Motor Neuron Disease: Characteristics of a Cross-Sectional Population  
  Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisanuki Y, Simmons Z, Maragakis NJ, McVey AL, Al-Lahham T, Heiman-Patterson TD, Andrews J, McDonnell E, Cu..., Journal of clinical neuromuscular disease, 1/1/2016
• Differential action of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts; implications for orexinergic signaling in ar...  
  Kholmeier KA, Tyler CJ, Kalogiannis M, Ishibashi M, Kristensen MP, Gumenchuk I, Chemelli RM, Kisanuki YY*, Yanagisawa M, Leonard CS, Front Neurosci., 1/20/2013
• Pathogenesis of autosomal dominant hereditary spastic paraplegia (SPG6) revealed by a rat model  
  Watanabe F, Arnold WD, Hammer RE, Ghodsizadeh O, Moti H, Schumer M, Hashmi A, Hernandez A, Sneh A, Sahenk Z, Kisanuki YY*, J Neuropathol Exp Neurol, 1/1/2013
• Lessons learnt from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab  
  Boster AL, Nicholas JA, Topalli I, Kisanuki YY*, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D, JAMA Neurol., 1/1/2013
• Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice  
  Kalogiannis M, Hsu E, Willie JT, Chemelli RM, Kisanuki YY*, Yanagisawa M, Leonard CS, PLoS One, 1/13/2011
• Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-tomesennchymal transition  
  Widyantoro B, Emoto N, Nakayama K, Anggrahini DW, Adiarto S, Iwasa N, Yagi K, Miyagawa K, RIkitake Y, Suzuki T, Kisanuki YY*, Yanagisawa M, Hirata K, Circulation, 1/8/2010
• Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states  
  Hondo M, Nagai K, Ohno K, Kisanuki Y, Willie JT, Watanabe T, Yanagisawa M, Sakurai T, Acta Physiol (Oxf)., 1/1/2010
• Low blood pressure in endothelial cell-specific endothelin 1 knockout mice  
  Kisanuki YY*, Emoto N, Ohuchi T, Widyantoro B, Yagi K, Nakayama K, Kedzierski RM, Hammer RE, Yanagisawa H, Williams SC, Richardson JA, Suzuki T, Yanagisawa M, Hypertension, 1/1/2010
• Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in lateralodorsal tegmental neurons  
  Kalogiannis M, Grupke SL, Potter PE, Edwards JG, Chemelli RM, Kisanuki YY*, Yanagisawa M, Leonard CS, Eur J Neurosci, 1/1/2010
• Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity  
  Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, Sakurai T, Yanagisawa M, Cell Metab., 1/7/2009
• Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation  
  Anggrahini DW, Emoto N, Nakayama K, Widyantoro B, Adiarto S, Iwasa N, Nonaka H, RIkitake Y, Kisanuki YY*, Yanagisawa M, Hirata K, Cardiovasc Res., 1/1/2009
• Late-onset mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with bitemporal lesions  
  Kisanuki YY*, Gruis KL, Smith TL, Brown DL, Arch Neurol, 1/1/2006
• Role of Endothelin 1 in the Pathogenesis of Chronic Chagasic Heart Disease  
  Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, Weiss LM, Factor SM, Shtutin V, Mukherjee S, Kitsis RN, Christ GJ, Wittner M, Sirani J, Kisanuki YY*, Yanagisawa M, Infection and Immunity, 1/1/2005
• Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes  
  Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY*, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RF, Yanagisawa M, Neuron, 1/1/2003
• The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance  
  Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY*, Bursell S, Yanagisawa M, King GL, Kahn CR, J Clin Invest, 1/1/2003
• Role of cardiac myocyte-derived endothelin-1 in chagasic cardiomyopathy: molecular genetic evidence  
  Huang H, Yanagisawa M, Kisanuki YY*, Jelicks LA, Chandra M, Factor SM, Wittner M, Weiss LM, Pestell RG, Shtutin V, Shirani J, Tanowitz HB, Clin Sci (Lond), 1/1/2002
• Tie-2 Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo  
  Kisanuki YY*, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M, Dev Biol, 1/1/2001
• Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation  
  Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammel T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M, Cell, 1/1/1999
• Join now to see all

Lectures

• ALSP 
  1/1/2018
• Cerebrotendinous Xanthomatosis 
  1/1/2016
• CADASIL 
  1/1/2011
• Pathophysiology and Therapeutic Approach in the Hereditary Spastic Paraplegia 
  1/1/2010
• MELAS 
  1/1/2009
• X-linked hereditary spastic paraplegia: SPG2 
  1/1/2008
• X-linked hereditary spastic paraplegia: SPG2 - a novel PLP1 mutation 
  1/1/2008
• Progressive Gait Disturbance in human and rodent 
  1/1/2008
• Adult-onset, autosomal dominant leukodystrophy 
  1/1/2007
• Research Presentation: Hereditary Spastic Paraplegia/SPG6 
  1/1/2006
• Non-diabetic Lumbosacral Polyradiculoneuropathy 
  1/1/2004
• Join now to see all